About

Dr. Zachary Hamilton is a leading urologic oncologist and robotic surgeon whose research has fundamentally advanced the surgical management of kidney cancer. His work centers on optimizing surgical approaches—specifically comparing retroperitoneal and transperitoneal robotic partial nephrectomy—to maximize both oncologic control and renal function preservation. Dr. Hamilton’s landmark 2017 study on Pentafecta outcomes (52 citations) established new benchmarks for perioperative and functional success in robotic kidney surgery. He has been instrumental in demonstrating the benefits of robotic surgery for complex cases, including elderly patients over 75 (33 citations) and those with clinical T2a renal masses (28 citations), showing improved trifecta outcomes over open surgery. His multicenter analysis on neoadjuvant sunitinib for inferior vena caval thrombus (41 citations) represents a critical advance in managing advanced disease. Dr. Hamilton’s contributions extend to population-level analyses using the National Cancer Database, and he has authored rare case reports on adrenal-renal fusion anomalies. With over 200 total citations, his work directly shapes clinical guidelines and surgical decision-making for kidney cancer patients worldwide.

Research Focus

Key Achievements

7
H-Index
12
Papers
223
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of retroperitoneal and transperitoneal robotic partial nephrectomy for Pentafecta perioperative and renal functional outcomes
52 citations · 2017
📈 Most Prolific Year: 2019 (4 Papers)
🤝 Key Collaborators: 102
🏛 Institutions: UC San Diego Health System, University of California San Diego, Moores Cancer Center, Saint Louis University, University of California San Diego Medical Center, University of Kansas

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago